Decide at what price you'd be comfortable buying and we'll help you stay ready.
Dexcom makes continuous glucose monitoring systems for people with diabetes. Its core product is a small wearable sensor that tracks glucose levels through the day and sends readings to a smartphone, receiver, or insulin pump, so users can manage blood sugar without repeated finger sticks. The company also sells the software and connected apps that display trends and alerts.
Its main customers are people with diabetes, along with the doctors, clinics, hospitals, and insurance plans that recommend, prescribe, or reimburse the devices. Dexcom makes money mostly by selling the disposable sensors and other consumables that patients replace regularly, plus related receivers and accessories. That gives the business a recurring revenue pattern rather than a one-time device sale.
What makes Dexcom different is that it sits between medical devices and digital health. It does not just make hardware; it sells an ongoing monitoring service built around data, alerts, and software that help patients and caregivers respond quickly to glucose changes. In the diabetes care chain, Dexcom is a key provider of real-time glucose data used to guide daily treatment decisions.
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more